We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Amends Emergency Use Authorization for COVID-19 Convalescent Plasma
FDA Amends Emergency Use Authorization for COVID-19 Convalescent Plasma
The FDA has revised its Emergency Use Authorization (EUA) for COVID-19 convalescent plasma, allowing only plasma with high antibody titers and only for hospitalized patients with early infections or patients with impaired immunity.